Jose Canseco and Human Genetic Engineering
By Osagie Obasogie,
Cincinnati Enquirer
| 10. 21. 2005
Will He Be Right Again?
Recently, Jose Canseco and I were guests on a talk show to discuss gene doping, the genetic equivalent to anabolic steroids - a way to "juice up" to gain a competitive edge. It is possible that in the next few years athletes will be able to enhance their performance by altering their genetic make-ups. Canseco argued that gene doping "is definitely the next big step in evolution." Genetic enhancement, he said, "goes way beyond sports. Imagine an army of a million individuals who can out-think, out-use the environment in the sense of less food, more reaction time, better vision, better physical reaction . . . (T)he human race . . . is going to evolve and no one's gonna stop it."
It's easy to dismiss this as the ramblings of a B-list star struggling to keep himself in the limelight. Indeed, when Canseco released his now infamous "Juiced: Wild Times, Rampant 'Roids, Smash Hits, and How Baseball Got Big," this was most people's response. Yet we have been forced to swallow the bitter truthfulness of Canseco's pill. In the few...
Related Articles
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...